Skip to main content
Erschienen in: Virchows Archiv 1/2019

29.09.2018 | Original Article

Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies

verfasst von: Napaporn Puripat, Kongsak Loharamtaweethong

Erschienen in: Virchows Archiv | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Mitotic figure (MF) counting is important in the evaluation of meningioma grading. Nevertheless, mitosis assessment on hematoxylin and eosin (H&E)-stained slides may be problematic because of technical factors and pathologist’s experience. Phosphohistone H3 (PHH3) is a mitosis-specific antibody that has proven to facilitate mitotic count in various tumors. However, the antibody performance between PHH3 serine10 (S10) and serine28 (S28) has never been compared in these tumors before. In this study, 48 cases of meningioma (28 grade I, 14 grade II, 6 grade III) were evaluated using immunohistochemical stains for four commercially available PHH3 (S10) and S28 antibodies to identify MFs and validate PHH3 intra- and interobserver reproducibility and agreement. Two pathologists counted MFs on both H&E- and PHH3-stained slides. H&E and PHH3 MFs were highly correlated (Spearman’s rho = 0.96 for PHH3 (S10)-Biocare, 0.96 for PHH3 (S10)-CST, 0.91 for PHH3 (S28)-Abcam, and 0.89 for PHH3 (S28)-Santa Cruz. The mean difference between an H&E and PHH3 mitotic count is 0.81 for PHH3 (S10)-Biocare, 0.95 for PHH3 (S10)-CST, − 0.97 for PHH3 (S28)-Abcam, and − 0.97 for PHH3 (S28)-Santa Cruz. For comparison among four PHH3 antibodies, PHH3 mitotic counts had both a good intra- and interobserver reproducibility (p > 0.05). Regarding to World Health Organization (WHO) grade, there was not a significant discrepancy in the stratification of tumor grades for all four PHH3 antibodies in terms of interobserver agreement. The Cohen’s kappa coefficient (K) was 0.93 for PHH3 (S10)-Biocare, 0.82 for PHH3 (S10)-CST, 0.76 for PHH3 (S28)-Abcam, and 0.80 for PHH3 (S28)-Santa Cruz. Considering survival analyses, all five proliferation indices were univariately associated with recurrences. Increased PHH3 mitotic indices (MIs) were significantly associated with recurrence-free survival in univariate Cox proportional hazards regression analysis (p < 0.001) and remained an independent predictor in multivariate analysis (p < 0.05). The appropriate prognostic cutoff values for recurrence prediction were 5 or more per 10 high-power fields (HPFs) for PHH3 (S10) and 3 or more per 10 HPFs for PHH3 (S28).
Literatur
1.
Zurück zum Zitat Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–297CrossRefPubMedPubMedCentral Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–297CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Reference WHO Kleihues P, Cavenee WK. eds. Meningiomas. In: Pathology and genetics of tumours of the nervous system: World Health Organization classification of tumours. Lyon: IARC Press; 2000:176–184 Reference WHO Kleihues P, Cavenee WK. eds. Meningiomas. In: Pathology and genetics of tumours of the nervous system: World Health Organization classification of tumours. Lyon: IARC Press; 2000:176–184
3.
Zurück zum Zitat Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th’ng JPH (1998) Chromatin condensation is not associated with apoptosis. J Biol Chem 273:24470–24478CrossRefPubMed Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th’ng JPH (1998) Chromatin condensation is not associated with apoptosis. J Biol Chem 273:24470–24478CrossRefPubMed
4.
Zurück zum Zitat Gurley LR et al (1978) Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Â Eur J Biochem 84:1–15CrossRefPubMed Gurley LR et al (1978) Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Â Eur J Biochem 84:1–15CrossRefPubMed
5.
Zurück zum Zitat Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K (2006) Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30:83–89CrossRefPubMed Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K (2006) Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30:83–89CrossRefPubMed
6.
Zurück zum Zitat Bossard C, Jarry A, Colombeix C, Bach-Ngohou K, Moreau A, Loussouarn D, Mosnier JF, Laboisse CL (2006) Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol 59:706–710CrossRefPubMedPubMedCentral Bossard C, Jarry A, Colombeix C, Bach-Ngohou K, Moreau A, Loussouarn D, Mosnier JF, Laboisse CL (2006) Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol 59:706–710CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Skaland I, Janssen EA, Gudlaugsson E et al (2007) Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Mod Pathol 20:1307–1315CrossRefPubMed Skaland I, Janssen EA, Gudlaugsson E et al (2007) Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Mod Pathol 20:1307–1315CrossRefPubMed
8.
Zurück zum Zitat Nasr MR, el-Zammar O (2008) Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 30:117–122CrossRefPubMed Nasr MR, el-Zammar O (2008) Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 30:117–122CrossRefPubMed
9.
Zurück zum Zitat PS N, Riber-Hansen R, Jensen TO, Schmidt H, Steiniche T (2013 Mar) Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma. Mod Pathol 26(3):404–413CrossRef PS N, Riber-Hansen R, Jensen TO, Schmidt H, Steiniche T (2013 Mar) Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma. Mod Pathol 26(3):404–413CrossRef
10.
Zurück zum Zitat Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K (2006) Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 30:657–664CrossRefPubMed Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K (2006) Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 30:657–664CrossRefPubMed
11.
Zurück zum Zitat Ribalta T, McCutcheon IE, Aldape KD et al (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28:1532–1536CrossRefPubMed Ribalta T, McCutcheon IE, Aldape KD et al (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28:1532–1536CrossRefPubMed
12.
Zurück zum Zitat Winther TL, Arnli MB, Salvesen O, Torp SH (2016) Phosphohistone-H3 proliferation index is superior to mitotic index and MIB-1 expression as a predictor of recurrence in human meningiomas. Am J Clin Pathol 146(4):510–520CrossRefPubMed Winther TL, Arnli MB, Salvesen O, Torp SH (2016) Phosphohistone-H3 proliferation index is superior to mitotic index and MIB-1 expression as a predictor of recurrence in human meningiomas. Am J Clin Pathol 146(4):510–520CrossRefPubMed
14.
Zurück zum Zitat Hendzel MJ, Wei Y, Mancini MA, van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP, Allis CD (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348–360CrossRefPubMed Hendzel MJ, Wei Y, Mancini MA, van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP, Allis CD (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348–360CrossRefPubMed
15.
Zurück zum Zitat Endl E, Steinbach P, Knuchel R et al (1997) Analysis of cell cycle–related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 29:233–241CrossRefPubMed Endl E, Steinbach P, Knuchel R et al (1997) Analysis of cell cycle–related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 29:233–241CrossRefPubMed
16.
Zurück zum Zitat Sun A, Zhou W, Lunceford J, Strack P, Dauffenbach LM, Kerfoot CA (2012) Level of phosphohistone H3 among various types of human cancers. BMJ Open 2:e001071CrossRefPubMedPubMedCentral Sun A, Zhou W, Lunceford J, Strack P, Dauffenbach LM, Kerfoot CA (2012) Level of phosphohistone H3 among various types of human cancers. BMJ Open 2:e001071CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M (2009) Sensitivity and usefulness of anti phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol 26:51–57CrossRefPubMed Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M (2009) Sensitivity and usefulness of anti phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol 26:51–57CrossRefPubMed
18.
Zurück zum Zitat Casper DJ, Ross KI, Messina JL, Sondak VK, Bodden CN, McCardle TW, Glass LF (2010) Use of anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. Am J Dermatopathol 32:650–654CrossRefPubMed Casper DJ, Ross KI, Messina JL, Sondak VK, Bodden CN, McCardle TW, Glass LF (2010) Use of anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. Am J Dermatopathol 32:650–654CrossRefPubMed
19.
Zurück zum Zitat Tsuta K, Liu DC, Kalhor N, Wistuba II, Moran CA (2011) Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol 136:252–259CrossRefPubMed Tsuta K, Liu DC, Kalhor N, Wistuba II, Moran CA (2011) Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol 136:252–259CrossRefPubMed
20.
Zurück zum Zitat Schimming TT, Grabellus F, Roner M, Pechlivanis S, Sucker A, Bielefeld N, Moll I, Schadendorf D, Hillen U (2012) pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas. Am J Dermatopathol 34:266–269CrossRefPubMed Schimming TT, Grabellus F, Roner M, Pechlivanis S, Sucker A, Bielefeld N, Moll I, Schadendorf D, Hillen U (2012) pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas. Am J Dermatopathol 34:266–269CrossRefPubMed
21.
Zurück zum Zitat Dessauvagie BF, Thomas C, Robinson C, Frost FA, Harvey J, Sterrett GF (2015) Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray. Pathology 47:329–334CrossRefPubMed Dessauvagie BF, Thomas C, Robinson C, Frost FA, Harvey J, Sterrett GF (2015) Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray. Pathology 47:329–334CrossRefPubMed
22.
Zurück zum Zitat Cui X, Harada S, Shen D, Siegal GP, Wei S (2015) The utility of phosphohistone H3 in breast cancer grading. Appl Immunohistochem Mol Morphol 23:689–695CrossRefPubMed Cui X, Harada S, Shen D, Siegal GP, Wei S (2015) The utility of phosphohistone H3 in breast cancer grading. Appl Immunohistochem Mol Morphol 23:689–695CrossRefPubMed
23.
Zurück zum Zitat Shin Y, Hyeon J, Lee B, Ha SY, Hong ME, Do IG, Kim KM (2015) PHH3 as an ancillary mitotic marker in gastrointestinal stromal tumors. J Pathol Transl Med 49:23–29CrossRefPubMedPubMedCentral Shin Y, Hyeon J, Lee B, Ha SY, Hong ME, Do IG, Kim KM (2015) PHH3 as an ancillary mitotic marker in gastrointestinal stromal tumors. J Pathol Transl Med 49:23–29CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Rudà R, Cassoni P (2015) Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Neuro-Oncology 17:663–669CrossRefPubMedPubMedCentral Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Rudà R, Cassoni P (2015) Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Neuro-Oncology 17:663–669CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ozturk Sari S, Taskin OC, Gundogdu G, Yegen G, onder S, Keskin M, Saglam S, Ozluk Y, Gulluoglu M, Mete O (2016) The impact of phosphohistone-H3-assisted mitotic count and Ki67 score in the determination of tumor grade and prediction of distant metastasis in well-differentiated pancreatic neuroendocrine tumors. Endocr Pathol 27:162–170CrossRefPubMed Ozturk Sari S, Taskin OC, Gundogdu G, Yegen G, onder S, Keskin M, Saglam S, Ozluk Y, Gulluoglu M, Mete O (2016) The impact of phosphohistone-H3-assisted mitotic count and Ki67 score in the determination of tumor grade and prediction of distant metastasis in well-differentiated pancreatic neuroendocrine tumors. Endocr Pathol 27:162–170CrossRefPubMed
26.
Zurück zum Zitat Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S (2009) Delay to formalin fixation effect on breast biomarkers. Mod Pathol 22:1457–1467CrossRefPubMed Khoury T, Sait S, Hwang H, Chandrasekhar R, Wilding G, Tan D, Kulkarni S (2009) Delay to formalin fixation effect on breast biomarkers. Mod Pathol 22:1457–1467CrossRefPubMed
27.
Zurück zum Zitat Van Diest PJ, Baak JPA, Matze-Cok P et al (1992) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23:603–607CrossRefPubMed Van Diest PJ, Baak JPA, Matze-Cok P et al (1992) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23:603–607CrossRefPubMed
28.
Zurück zum Zitat Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histological parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histological parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed
Metadaten
Titel
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies
verfasst von
Napaporn Puripat
Kongsak Loharamtaweethong
Publikationsdatum
29.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2019
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-018-2458-2

Weitere Artikel der Ausgabe 1/2019

Virchows Archiv 1/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie